BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25741445)

  • 1. Pelvic exenteration: experience from a rural cancer center in developing world.
    Dessai SB; Balasubramanian S; Patil VM; Chakraborty S; Bhattacharjee A; Vikram S
    Int J Surg Oncol; 2015; 2015():729658. PubMed ID: 25741445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-institution approach to total pelvic exenteration.
    Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
    Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
    Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
    Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center.
    Lopez MJ; Standiford SB; Skibba JL
    Arch Surg; 1994 Apr; 129(4):390-5; discussion 395-6. PubMed ID: 8154965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration: a 15-year experience in a general metropolitan hospital.
    Averette HE; Lichtinger M; Sevin BU; Girtanner RE
    Am J Obstet Gynecol; 1984 Sep; 150(2):179-84. PubMed ID: 6476039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urgent Pelvic Exenteration: Should the Indication Be Extended?
    Thiptanakit C; Chowchankit I; Panya S; Kanjanasilp P; Malakorn S; Pattana-Arun J; Sahakitrungruang C
    Dis Colon Rectum; 2018 May; 61(5):561-566. PubMed ID: 29624550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.
    Nguyen DQ; McGregor AD; Freites O; Carr ND; Beynon J; El-Sharkawi AM; Lucas MG
    Eur J Surg Oncol; 2005 Dec; 31(10):1180-4. PubMed ID: 16126362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration.
    Lindsey WF; Wood DK; Briele HA; Greager JA; Walker MJ; Bork J; Das Gupta TK
    J Surg Oncol; 1985 Dec; 30(4):231-4. PubMed ID: 2417058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of palliative pelvic exenteration.
    Brophy PF; Hoffman JP; Eisenberg BL
    Am J Surg; 1994 Apr; 167(4):386-90. PubMed ID: 7513967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.
    Young JM; Badgery-Parker T; Masya LM; King M; Koh C; Lynch AC; Heriot AG; Solomon MJ
    Br J Surg; 2014 Feb; 101(3):277-87. PubMed ID: 24420909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
    Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
    Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
    Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
    Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative pelvic exenteration--futility revisited.
    McCullough WM; Nahhas WA
    Gynecol Oncol; 1987 May; 27(1):97-103. PubMed ID: 2436983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.